Ironwood(IRWD) - 2025 Q4 - Earnings Call Transcript

Ironwood Pharmaceuticals (NasdaqGS:IRWD) Q4 2025 Earnings call February 25, 2026 08:30 AM ET Company ParticipantsAmy Li - SVP of Equity ResearchGregory Martini - SVP and CFOMichael Shetzline - Chief Medical OfficerTammi Gaskins - Chief Commercial OfficerThomas McCourt - CEOConference Call ParticipantsChase Knickerbocker - Senior Equity Research AnalystDominic Rose - Equity Research AnalystJason Butler - Managing Director and Senior Biotechnology Equity Research AnalystMohit Bansal - Managing Director and Se ...